A personal story from our President:
Renal Devices was started as a result of the treatment received by a friend for a high flow AV access. His inordinate suffering was mainly due to the inability to controllably band a medium sized blood conduit.
It was clear that there were no devices for this application, with all clinical banding techniques being personal-preference. Renal Devices was started to fill that need. With no predicates, a new approach was required which evolved into the Flowband device.
President
A chemical engineer with a specialty in polymers, Mr. Lauren’s work centered around developing implantable cardiovascular devices. He started a subsidiary of Cordis Corporation in Melbourne, Australia growing vascular grafts in sheep. His technical interests are broad. He developed the first mass customized system for producing dental splints, a 4-dimensional camera for capturing jaw motion, custom test systems for cardiac valves, light-cure dental materials, and mechanochemical test equipment.
Consultant
Dr. John Ross is widely recognized as a leading expert in vascular access. A founding member of the Vascular Access Society of the Americas and was given the Lifetime Achievement Award by the American Society of Diagnostic and Interventional Radiology (ASDIN). Dr. Ross is a Fellow of both the American College of Surgeons and ASDIN. Dr. Ross has served as the PI on numerous industry trials, spoken at dozens of medical meetings around the world and has published on a wide variety of topics related to vascular access.
Consultant
Academically trained in biology and chemistry Kem’s scientific career has focused primarily on the industrial research and development of Class III biomedical devices. His accomplishments include the invention, research, development and commercialization of a number of world class products, including Hemashield, the first collagen coated vascular conduit, PeriStrips, the first lung volume reduction staple line buttressing product, MitralSeal, the first transcatheter mitral valve prosthesis, and ArterX, a surgical sealant. Kem co-founded Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies, that was acquired by Abbott in 2015.
Consultant
A former Product Development Engineer with Fisher-Price, D’Arcy Development provides conceptual design and engineering input to the development process, including 3D concept modelling, 2D drawings, and graphics.
Development Engineer
A biomedical engineer and nurse with an extensive background in orthopedic surgery. Mr. Pitkin provides general engineering support which includes all aspects of in vitro testing and FDA documentation aligned with 21 CFR Part 820
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.